No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
COCO240621P30000
- 0.60
- +0.05+9.09%
15min DelayClose Jun 14 15:59 ET
0.60High0.60Low
0.60Open0.55Pre Close1 Volume116 Open Interest30.00Strike Price60.00Turnover25.87%IV0.64%PremiumJun 21, 2024Expiry Date0.41Intrinsic Value100Multiplier5DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type-0.6569Delta0.4001Gamma49.32Leverage Ratio-0.0305Theta-0.0025Rho-32.39Eff Leverage0.0132Vega
Intraday
- 5D
- 1D
News
Form 144 | Vita Coco(COCO.US) Officer Proposes to Sell 606K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $Vita Coco(COCO.US)$ Officer CHARLES VAN ES intends to sell 20,000 shares of its common stock on Jun 14, with a total market value of approximately $606K. Source: An
Form 144 | Vita Coco(COCO.US) Officer Proposes to Sell 303K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $Vita Coco(COCO.US)$ Officer JANE PRIOR intends to sell 10,000 shares of its common stock on Jun 14, with a total market value of approximately $303K. Source: Announ
Vita Coco Company, Inc. (COCO) Stock Declines While Market Improves: Some Information for Investors
AB InBev (BUD) Stays on Growth Track on Ongoing Initiatives
Wells Fargo Maintains Vita Coco(COCO.US) With Buy Rating, Maintains Target Price $30
Wells Fargo analyst Christopher Carey maintains $Vita Coco(COCO.US)$ with a buy rating, and maintains the target price at $30.According to TipRanks data, the analyst has a success rate of 56.1% and a
Bull of the Day: Vita Coco (COCO)
Comments
CEOs of VITAS and Covenant Care laud the acquisition, emphasizing their shared mission and values. The move is seen as strategic, enabling Covenant Care to enhance community healthcare, while VITAS can build on Covenant Care's legacy of quality, patient-centered care.
Press Release: VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama 1
Despite Vita Coco's high P/E ratio, investors hold onto their stock expecting the company to continue defying market adversity. However, if the P/E falls in line with the growth outlook, this could disappoint. The high share price and future earnings predictions may not support this optimism for long, risking shareholders' investments and potential investors paying an unnecessary premium.
1
$Vita Coco(COCO.US$ rocketed
Vita Coco's Q4 results outperformed expectations, but its full-year revenue guidance was slightly disappointing. However, its strong cash profitability gives it an edge over competitors.
$Vita Coco(COCO.US$ who is drinking this
Read more